Credit Suisse’s Arbutus Biopharma ABUS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-1,102
Closed -$2.57K 3263
2022
Q4
$2.57K Buy
1,102
+483
+78% +$1.16K ﹤0.01% 3542
2022
Q3
$1K Buy
619
+618
+61,800% +$1.46K ﹤0.01% 3792
2022
Q2
$0 Buy
+1
New +$3 ﹤0.01% 3875
2022
Q1
Sell
-11,271
Closed -$44K 3570
2021
Q4
$44K Buy
+11,271
New +$43.8K ﹤0.01% 4424
2021
Q3
Sell
-86,771
Closed -$262K 4374
2021
Q2
$262K Sell
86,771
-18,395
-17% -$57K ﹤0.01% 4171
2021
Q1
$350K Buy
105,166
+86,015
+449% +$332K ﹤0.01% 3945
2020
Q4
$68K Buy
+19,151
New +$67.1K ﹤0.01% 4216
2020
Q2
Sell
-216,708
Closed -$219K 3929
2020
Q1
$219K Buy
216,708
+71,498
+49% +$193K ﹤0.01% 3598
2019
Q4
$403K Buy
+145,210
New +$235K ﹤0.01% 3676
2018
Q3
Sell
-11,436
Closed -$84K 3761
2018
Q2
$84K Buy
+11,436
New +$68.1K ﹤0.01% 3852
2017
Q4
Sell
-176,091
Closed -$1.09M 3959
2017
Q3
$1.09M Buy
176,091
+91
+0.1% +$389 ﹤0.01% 3031
2017
Q2
$634K Sell
176,000
-1
-0% -$3 ﹤0.01% 2985
2017
Q1
$572K Sell
176,001
-79
-0% -$219 ﹤0.01% 3199
2016
Q4
$431K Sell
176,080
-1,180
-0.7% -$3.43K ﹤0.01% 3519
2016
Q3
$610K Buy
177,260
+990
+0.6% +$3.87K ﹤0.01% 3309
2016
Q2
$613K Buy
176,270
+120
+0.1% +$508 ﹤0.01% 3291
2016
Q1
$727K Sell
176,150
-81
-0% -$289 ﹤0.01% 2968
2015
Q4
$785K Sell
176,231
-5,421
-3% -$29.7K ﹤0.01% 3022
2015
Q3
$1.11M Buy
181,652
+36,470
+25% +$323K ﹤0.01% 2731
2015
Q2
$1.72M Buy
145,182
+63,363
+77% +$964K ﹤0.01% 2671
2015
Q1
$1.43M Buy
+81,819
New +$1.68M ﹤0.01% 2690
2014
Q3
Sell
-33,688
Closed -$440K 4418
2014
Q2
$440K Sell
33,688
-3,716
-10% -$52.7K ﹤0.01% 3907
2014
Q1
$804K Buy
+37,404
New +$672K ﹤0.01% 3319

Other funds holding ABUS